# Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis

> **NCT00941317** · PHASE1 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 25 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DEVICE:** Pathformer (micro-drilling device)

## Key facts

- **NCT ID:** NCT00941317
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941317, "Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis". Retrieved via MORVS 2026-10-26 from https://api.morvs.ai/clinical/NCT00941317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*